/Investor DB

Northern Gritstone — 2024 Investments

5 investments dated 2024 · listed companies and verified rows first · show all

Adsilicoadsilico.ukFeb 2024

adsilico builds generative AI technology that creates diverse virtual patient populations—digital models of human anatomy, physiology, and pathology—to run in silico trials that assess medical device safety and performance before human testing.

AI & Machine LearningHealthtechMedical Devices

Dr Nishant RavikumarinDr Zeike TaylorinProf Alejandro FrangiSheena Macphersonin

Co-investorsParkwalk Advisors

Exciting Instrumentsexcitinginstruments.comin𝕏Nov 2024

Exciting Instruments builds the EI-FLEX benchtop platform, a single-molecule fluorescence instrument combining smFRET, FCS and FCCS to measure biomolecular interactions and dynamics directly in solution.

BiotechDeep TechHardware

Timothy Craggs(Founder and CEO)

Co-investorsCambridge Innovation CapitalEmpirical VenturesPraetura Ventures

Microlubmicrolub.cominOct 2024 · $10M

MicroLub is a UK-based deep-tech ingredient company that develops protein-based biolubricant molecules — protein microgels coated with polysaccharides — that reduce molecular friction to replace fats and oils in food and personal care products while retaining their mouthfeel and texture.

BiotechDeep TechFoodTechNew MaterialsLeeds, GB

Anwesha Sarkar(Founder)in

Co-investorsLIFTTPraetura Ventures

Partfulpartful.ioin𝕏Dec 2024

Partful builds a 3D interactive parts catalog platform that gives equipment operators and aftermarket end-users a real-time, immersive view of parts and repair instructions connected to the manufacturer.

Advanced ManufacturingEnterprise SoftwareLogistics & Supply ChainSaaS

Co-investorsBlumberg Capital

Phagenesisphagenesis.comin𝕏Mar 2024

Phagenesis develops targeted pharyngeal electrical stimulation technology to treat neurogenic dysphagia by restoring neural pathways for safe swallowing.

Deep TechDigital HealthHealthtechMedical Devices

Co-investorsAphelion CapitalInnvotec Ltd.EQT Life SciencesSectoral Asset Management

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.